Zoetis Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Zoetis Inc. (ZTS) shares rose 1.05% to $75.35, outperforming competitors Merck & Co. and IDEXX Laboratories on a favorable trading day. This marks the stock's second consecutive gain, though it remains 53.05% below its 52-week high of $160.48. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zoetis Inc. (ZTS) rose 1.05% to $75.35 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.05% to 7,411.98 and the Dow Jones Industrial Average rising 0.46% to 51,947.25.
This was the stock's second consecutive day of gains.
Zoetis Inc. closed 53.05% below its 52-week high of $160.48, which the company achieved on August 20th.
The stock outperformed some of its competitors Friday, as Merck & Co. Inc. (MRK) rose 0.45% to $131.07 and IDEXX Laboratories Inc. (IDXX) rose 0.92% to $544.32.
Trading volume (5.1 M) remained 2.2 million below its 50-day average volume of 7.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-24-26 1658ET